Publication | Open Access

Functional patient-derived organoid screenings identify MCLA-158 as a therapeutic EGFR × LGR5 bispecific antibody with efficacy in epithelial tumors

MedicineImmunologyTumor ImmunityPathologyEpithelial TumorsMolecular OncologyCancer TreatmentCancer GeneticsOncologyRadiation OncologyCancer Research